UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Current medicinal chemistry, ISSN 0929-8673, 01/2012, Volume 19, Issue 2, pp. 239 - 280
Triazole | Antifungal | Antidiabetic | Triazolium | Anticonvulsant | Antibacterial | Antihistaminic | Antitubercular | Analgesic | Anti-obesitic | Antiparasitic | Antiviral | Anticancer | Anti-inflammatory | Anti-neuropathic | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Antifungal Agents - pharmacology | Analgesics - pharmacology | Antiviral Agents - pharmacology | Antitubercular Agents - chemistry | Anti-Inflammatory Agents - pharmacology | Triazoles - chemistry | Antitubercular Agents - pharmacology | Antifungal Agents - chemistry | Hypoglycemic Agents - chemistry | Antineoplastic Agents - chemistry | Anticonvulsants - pharmacology | Hypoglycemic Agents - pharmacology | Triazoles - pharmacology | Anti-Inflammatory Agents - chemistry | Analgesics - chemistry | Antiviral Agents - chemistry | Anti-Bacterial Agents - chemistry | Anticonvulsants - chemistry | Antiparasitic Agents - pharmacology | Anti-Bacterial Agents - pharmacology | Antineoplastic Agents - pharmacology | Antiparasitic Agents - chemistry
Journal Article
Mayo Clinic proceedings, ISSN 0025-6196, 2011, Volume 86, Issue 6, pp. 561 - 583
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Antiparasitic agents | General aspects | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Trypanosomiasis, African - drug therapy | Toxoplasmosis - drug therapy | Cestode Infections - drug therapy | Humans | Parasitic Diseases - drug therapy | Giardiasis - drug therapy | Leishmaniasis - drug therapy | Nematode Infections - drug therapy | Trematode Infections - drug therapy | Protozoan Infections - drug therapy | Antiparasitic Agents - therapeutic use | Amebiasis - drug therapy | Chagas Disease - drug therapy | Helminthiasis - drug therapy | Malaria - drug therapy | Antiprotozoal Agents - therapeutic use | Anthelmintics - therapeutic use | Drug Resistance | Complications and side effects | Dosage and administration | Drug therapy | Parasitic diseases | Patient outcomes | Index Medicus | Abridged Index Medicus | Symposium on Antimicrobial Therapy
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 4/2005, Volume 40, Issue 8, pp. 1173 - 1180
Cryptosporidiosis | Parasitology | Diarrhea | Placebos | Clinical trials | Infections | Parasitism | Reviews of Anti-Infective Agents | Children | Parasites | Dosage | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Parasitic diseases | Pharmacology. Drug treatments | Protozoal diseases | Biological and medical sciences | Antiparasitic agents | Human protozoal diseases | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Parasitic Diseases - drug therapy | Thiazoles - chemistry | Molecular Structure | Thiazoles - pharmacology | Humans | Antiparasitic Agents - pharmacology | Protozoa | Cryptosporidium | Care and treatment | Worms, Intestinal and parasitic | Colorectal diseases | HIV (Viruses) | Drug testing | In vitro | Helminths | Giardia lamblia | Gastrointestinal diseases | Toxicity testing | Giardia | Pharmacokinetics | Side effects | Medical treatment | Protozoan enzymes | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2013, Volume 57, Issue 9, pp. 4151 - 4163
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Chagas Disease - parasitology | 14-alpha Demethylase Inhibitors - chemistry | Protozoan Proteins - antagonists & inhibitors | Golgi Apparatus - drug effects | Imidazoles - chemistry | Male | Trypanocidal Agents - chemistry | Endoplasmic Reticulum - ultrastructure | Trypanosoma cruzi - enzymology | Protozoan Proteins - metabolism | Oxadiazoles - pharmacology | Endoplasmic Reticulum - drug effects | Oxadiazoles - chemistry | Trypanosoma cruzi - ultrastructure | Golgi Apparatus - ultrastructure | Microscopy, Electron, Transmission | Nitroimidazoles - pharmacology | Drug Resistance - drug effects | Imidazoles - pharmacology | Triazoles - pharmacology | Animals | Trypanosoma cruzi - growth & development | 14-alpha Demethylase Inhibitors - pharmacology | Trypanocidal Agents - pharmacology | Chagas Disease - mortality | Chagas Disease - drug therapy | Trypanosoma cruzi - drug effects | Mice | Sterol 14-Demethylase - metabolism | Thiazoles - pharmacology | Index Medicus | Experimental Therapeutics
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2012, Volume 67, Issue 11, pp. 2576 - 2597
Cutaneous leishmaniasis | Alkylphosphocholine | Pharmacodynamics | Visceral leishmaniasis | Leishmania | Clinical pharmacology | Antiparasitic agents | Mechanism of action | Pharmacokinetics | Antiprotozoal agents | Pre-clinical pharmacology | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Leshmaniasis | Infectious diseases | Parasitic diseases | Pharmacology. Drug treatments | Protozoal diseases | Biological and medical sciences | Human protozoal diseases | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Leishmaniasis - drug therapy | Treatment Outcome | Clinical Trials as Topic | Phosphorylcholine - analogs & derivatives | Antiprotozoal Agents - pharmacology | Antiprotozoal Agents - pharmacokinetics | Antiprotozoal Agents - adverse effects | Phosphorylcholine - pharmacokinetics | Phosphorylcholine - pharmacology | Leishmania - drug effects | Phosphorylcholine - adverse effects | Antiprotozoal Agents - therapeutic use | Phosphorylcholine - therapeutic use | Clinical trials | Side effects | Parasites | Antibiotics | Cells | Cancer | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 8, pp. 687 - 695
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Helminthic diseases | Infectious diseases | Cysticercosis | Parasitic diseases | Diseases caused by cestodes | Pharmacology. Drug treatments | Biological and medical sciences | Antiparasitic agents | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Albendazole - therapeutic use | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Praziquantel - adverse effects | Praziquantel - therapeutic use | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Adolescent | Neurocysticercosis - drug therapy | Adult | Female | Aged | Anthelmintics - therapeutic use | Placebos - administration & dosage | Albendazole - adverse effects | Anthelmintics - adverse effects | Clinical trials | Seizures (Medicine) | Analysis | Hypertension | Hepatitis | Tuberculosis | Cysts | Medical treatment | Epilepsy | Cell division | Patient safety | Infections | Parasites